The Global Ventricular Assist Device Market was valued at $1,552.12 million in 2019 and it is expected to reach at $2,110.46 million by the end of 2025, growing at a Compound Annual Growth Rate (CAGR) of 5.25% during the forecast period of 2020 to 2025.
Market players included in research study of the global ventricular assist device Market are Jarvik Heart, Inc., Abiomed, Heart Ware International, Berlin Heart Gmbh, and Cardiac Assist., Inc.
Jarvik Heart, Inc.
Founded in 1988 and headquartered at New York. It is engaged in development of ventricular heart assist devices for the treatment of severe heart failure. Jarvik Heart has earned CE Mark Certification in Europe. In the United States and Japan, the Jarvik 2000 has been approved for bridge-to-transplant and for lifetime use.
Jarvik Heart has its presence in various countries. There have been around 1000 Jarvik 2000 implants across the globe.
Abiomed was founded in 1981 and headquartered at Danvers, Massachusetts, United States. It is a manufacturer of medical implant devices, including the AbioCor artificial heart and Impella.
With its strong network of distribution and subsidiaries, the company has its presence in various regions such as Japan, North America, and Rest of World. It is having three offices, two in Germany in the cities of Berlin and Aachen, and another in Japan. The major subsidiaries of Abiomed are Abiomed SARL, Abiomed Europe GmbH, Abiomed Athlone Ltd., ABD Holding Co Inc., Abiomed R&D Inc., Breethe, Inc., and Abiomed Limited.
Heart Ware International
Heart Ware International wasfounded in 2004 and headquartered at Framingham, Massachusetts, United States. HeartWare is a medical device company which is dedicated towards creating a revolutionary technology for the treatment of severe heart failure. It enables patients to get back to their life. Its parent organization is Medtronic, Inc.
With its strong network of distribution and subsidiaries, the company has its presence in various regions such as Europe, Asia-Pacific, North America, and Rest of World. The major subsidiaries of Heart Ware International Company are HeartWare Inc and HeartWare Ltd.
Berlin Heart GmbH
Berlin Heart GmbH was founded in 2000 and headquartered at Berlin, Germany. It is a German company which is engaged in development, production and marketing of ventricular assist devices. These devices mechanically support the hearts of the end-stage heart failure patients. Berlin Heart GmbH introduce products including the paracorporeal EXCOR VAD and the implantable INCOR VAD. The major subsidiary of the Berlin Heart GmbH is Berlin Heart Inc.
Cardiac Assist, Inc.
Cardiac Assist, Inc. was founded in 1996 and headquartered at Pittsburgh, Pennsylvania, United States. It is a manufacturer of medical devices used by cardiac surgeons and cardiologist. Cardiac Assist Company offers TandemLung oxygenator, temporary ventricular circulatory support device, a transseptal cannula for temporary left ventricular, and hydrodynamic centrifugal pump. Its parent organization is LivaNova PLC. Cardiac Assist has entered into an agreement to acquire TandemLife, a company that focused on advanced cardiopulmonary temporary support solutions. Cardiac Assist Inc. received a Class 3 CE-mark for its Protek Duo veno-venous cannula in 2015.